EUVIMEDEUVIMED entdecken
Crossref

0799 Gene expression predicts metastatic risk in low-risk cutaneous squamous cell carcinoma

B. Rentroia-Pacheco, L. Pozza, O. Steijlen, J. Traets, R. Ruiter, Y. Chen, D. Huigh, C. Eggermont, D. Baskurt, V. Arunachalam, A. Bas-Cristóbal Menéndez, T. Nijsten und 7 weitere

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S138

DOI: 10.1016/j.jid.2026.06.830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von B. Rentroia-Pacheco und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rentroia-Pacheco, B., Pozza, L., Steijlen, O., Traets, J., Ruiter, R., Chen, Y., Huigh, D., Eggermont, C., Baskurt, D., Arunachalam, V., Menéndez, A. B., Nijsten, T., Keulen, D. V., Shain, A., Werken, H. V. D., Mooyaart, A., Bellomo, D., Hollestein, L., & Wakkee, M. (2026). 0799 Gene expression predicts metastatic risk in low-risk cutaneous squamous cell carcinoma. Journal of Investigative Dermatology, 146(8), S138. https://doi.org/10.1016/j.jid.2026.06.830

Vancouver

Rentroia-Pacheco B, Pozza L, Steijlen O, Traets J, Ruiter R, Chen Y, et al. 0799 Gene expression predicts metastatic risk in low-risk cutaneous squamous cell carcinoma. Journal of Investigative Dermatology. 2026;146(8):S138. doi:10.1016/j.jid.2026.06.830

BibTeX
@article{RentroiaPacheco2026,
  author = {Rentroia-Pacheco, B. and Pozza, L. and Steijlen, O. and Traets, J. and Ruiter, R. and Chen, Y. and Huigh, D. and Eggermont, C. and Baskurt, D. and Arunachalam, V. and Menéndez, A. Bas-Cristóbal and Nijsten, T. and Keulen, D. van and Shain, A. and Werken, H. van de and Mooyaart, A. and Bellomo, D. and Hollestein, L. and Wakkee, M.},
  title = {0799 Gene expression predicts metastatic risk in low-risk cutaneous squamous cell carcinoma},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S138},
  doi = {10.1016/j.jid.2026.06.830}
}
Kostenlos starten →